Soru

Zorluk: OrtaInfectious Diseases

A 55-year-old man with poorly controlled type 2 diabetes mellitus is evaluated in the hospital on day 4 of admission for a severe diabetic foot infection. He initially presented with a deep, purulent ulcer on the plantar aspect of his right foot surrounded by extensive cellulitis. On admission, empiric therapy was initiated with intravenous vancomycin and piperacillin-tazobactam, and he subsequently underwent surgical debridement of necrotic tissue. Today, his temperature is 37.1∘C37.1^\circ\text{C} (98.8∘F98.8^\circ\text{F}), blood pressure is 128/78 mm Hg128/78\text{ mm Hg}, and pulse is 78/min78\text{/min}. The wound appears clean with developing granulation tissue. Deep tissue cultures obtained during surgery yield heavy growth of Staphylococcus aureus. Antimicrobial susceptibility testing demonstrates resistance to penicillin and susceptibility to oxacillin, cefazolin, and vancomycin. Which of the following is the most appropriate next step in pharmacotherapy?

  1. Discontinue current antibiotics and initiate intravenous cefazolinCevap
  2. B
    Discontinue piperacillin-tazobactam and continue intravenous vancomycin
  3. C
    Discontinue vancomycin and continue intravenous piperacillin-tazobactam
  4. D
    Continue both intravenous vancomycin and piperacillin-tazobactam
  5. E
    Discontinue current antibiotics and initiate intravenous daptomycin

Cevap

Discontinue current antibiotics and initiate intravenous cefazolin
The patient's cultures grew methicillin-susceptible Staphylococcus aureus (MSSA). For severe MSSA infections, such as osteomyelitis or deep tissue infections associated with diabetic foot ulcers, antistaphylococcal beta-lactams (e.g., cefazolin, nafcillin, oxacillin) are the treatment of choice. They have superior bactericidal activity and are associated with lower mortality and treatment failure rates compared to vancomycin. Therefore, the most appropriate step is to discontinue the broad-spectrum empiric regimen and initiate targeted therapy with intravenous cefazolin.

Adım Adım Çözüm

1
Interpret the culture and susceptibility results
The pathogen is methicillin-susceptible Staphylococcus aureus (MSSA), as indicated by susceptibility to oxacillin and cefazolin.
Identifying the specific organism and its resistance profile is essential for transitioning from empiric to targeted therapy.
2
Evaluate the current empiric antibiotic regimen
The patient is on vancomycin (MRSA coverage) and piperacillin-tazobactam (broad Gram-negative and anaerobic coverage).
Empiric therapy must be narrowed to prevent the development of resistance and minimize adverse drug events.
3
Select the optimal targeted therapy for MSSA
Intravenous cefazolin is chosen over vancomycin and piperacillin-tazobactam.
Antistaphylococcal beta-lactams (e.g., cefazolin, nafcillin, oxacillin) are superior to vancomycin for MSSA infections, offering faster bacterial clearance and lower mortality.

Anahtar Kavram

Methicillin-susceptible Staphylococcus aureus (MSSA) infections should be treated with narrow-spectrum antistaphylococcal beta-lactams (e.g., cefazolin, nafcillin, oxacillin) rather than vancomycin or broader-spectrum beta-lactams like piperacillin-tazobactam, in accordance with antimicrobial stewardship.
Bu soruyu puanla